Latest Press Releases
View all
TimeHeadline
11m agoPiramal Pharma Limited Announces Results for Q4 and Full-year FY26
11m agoU-BX Technology Ltd. Announces Closing of $4.55 Million Registered Direct Offering
11m agoMaryland American Water Proudly Recognizes American Water Charitable Foundation 2026 Water and Environment Grantees
37m agoAmeriprise Financial Named a Top Performer™ in Hearts & Wallets Customer Satisfaction Survey for the Eighth Time
37m agoMedallion Financial Corp. to Report 2026 First Quarter Results on Wednesday, April 29, 2026
Argen-x logo

Argen-x

About

Argen-x (NASDAQ:ARGX) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 18 2026
argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP
Mar 20 2026
argenx announces Annual General Meeting of Shareholders on May 6, 2026
Mar 6 2026
argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline
Feb 26 2026
argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
Feb 26 2026
argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update

Financials

Revenue
$4.24 B
Market Cap
$46.32 B
P/E Ratio
38.16
EPS
19.56

Community Chat

Ask AI

6ix6ixAIEvents